🇺🇸 FDA
Patent

US 11945855

Recombinant polypeptides comprising modified MHC class II DRa1 domains and methods of use

granted A61KA61K2039/55566A61K2039/6031

Quick answer

US patent 11945855 (Recombinant polypeptides comprising modified MHC class II DRa1 domains and methods of use) held by United States Government as represented by the Department of Veterans Affairs expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/55566, A61K2039/6031, A61K39/0008, A61P